Beiersdorf AG (Beiersdorf) a subsidiary of maxingvest ag, manufactures, markets, and sells skin care, personal care, and self-adhesive products. It offers its skin and body care products under NIVEA, Eucerin, La Prairie, Chantecaille, and Hansaplast brand names. As of December 2025, Beiersdorf had more than 190 affiliates worldwide.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Beiersdorf’s R&D arm focuses on development of new products with high potential and sustainable growth. In the Consumer business segment, the company develops innovative and high-quality skin care products. In the Tesa business segment, the company develops innovative adhesive tapes and self-adhesive solutions for industry, commercial customers, and end consumers. It also aims to develop sun care products that prevent general skin cancer. The key areas of research include epigenetics, hyperpigmentation, skin microbiome, anti-aging ingredients, and alternative testing methods. It focuses on ensuring product safety and quality, aligning with the new Medical Devices Regulation (MDR), and protecting intellectual property through global patents. As of December 2025, the company employed 1,200 people in its R&D division. In FY2025, the company had global portfolio of over 1,867 active patents around the world and 1,084 patent filings were in the ongoing grant procedure. It filed 70 new patents. The company operates research center in Hamburg, Germany. Beiersdorf performed 325 studies at the Beiersdorf study center with 7,100 participants and conducted 1,610 studies with 90,000 participants internationally. It also opened regional R&D laboratories in Brazil, China, India, and Japan. In FY2025, Beiersdorf incurred R&D expenses of EUR365 million, which as a percentage of revenue, stood at 3.7%.